Lexaria Bioscience Corp. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q2 2024 | 2 | -$0.13 | -$0.10 | -$0.12 |
| Q3 2024 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q1 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q2 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q3 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
Lexaria Bioscience Corp. Earnings Date And Information
Lexaria Bioscience Corp. last posted its earnings results on Friday, July 12th, 2024. The company reported $-0.13 earnings per share for the quarter, missing analysts' consensus estimates of $-0.09 by $0.04. The company had revenue of 84,000 for the quarter and had revenue of 226,208 for the year. Lexaria Bioscience Corp. has generated $-1 earnings per share over the last year ($-1.01 diluted earnings per share) and currently has a price-to-earnings ratio of -6.14. Lexaria Bioscience Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, January 10th, 2025 based on prior year's report dates.
Lexaria Bioscience Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 07/12/2024 | Q3 2024 | -$0.09 | -$0.13 | -0.04 | $106,000 | $84,000 |
| 04/09/2024 | Q2 2024 | -$0.10 | -$0.06 | 0.04 | $145,000 | |
| 01/12/2024 | Q1 2024 | -$0.11 | -$0.13 | -0.02 | $151,278 | |
| 11/20/2023 | Q4 2023 | -$0.19 | $10,000 | $-3,433 | ||
| 07/14/2023 | Q3 2023 | -$0.25 | -$0.37 | -0.12 | $93,150 | |
| 04/14/2023 | Q2 2023 | -$0.22 | $35,015 | |||
| 01/18/2023 | Q1 2023 | -$0.30 | $101,476 | |||
| 11/25/2022 | Q4 2022 | -$0.25 | $120,000 | $111,150 | ||
| 07/14/2022 | Q3 2022 | -$0.28 | -$0.40 | -0.12 | $150,000 | $99,717 |
| 04/11/2022 | Q2 2022 | -$0.21 | -$0.24 | -0.03 | $30,650 | |
| 01/14/2022 | Q1 2022 | -$0.35 | $13,880 | |||
| 11/26/2021 | Q4 2021 | -$0.23 | -$0.23 | 0 | $31,021 | |
| 07/15/2021 | Q3 2021 | -$0.50 | $204,055 | |||
| 04/14/2021 | Q2 2021 | $0.09 | $192,006 | |||
| 01/14/2021 | Q1 2021 | -$0.23 | $295,656 | |||
| 10/14/2020 | Q4 2020 | -$0.14 | $133,739 | |||
| 06/30/2020 | Q3 2020 | -$0.49 | $81,423 | |||
| 04/02/2020 | Q2 2020 | -$0.36 | $107,299 | |||
| 01/08/2020 | Q1 2020 | -$0.34 | $62,082 | |||
| 11/14/2019 | Q4 2019 | -$0.41 | $125,121 |
Lexaria Bioscience Corp. Earnings: Frequently Asked Questions
-
When is Lexaria Bioscience Corp.'s earnings date?
Lexaria Bioscience Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, January 10th, 2025 based off last year's report dates.
-
How can I listen to Lexaria Bioscience Corp.'s earnings conference call?
The conference call for Lexaria Bioscience Corp.'s latest earnings report can be listened to online.
-
How can I read Lexaria Bioscience Corp.'s conference call transcript?
The conference call transcript for Lexaria Bioscience Corp.'s latest earnings report can be read online.
-
How much revenue does Lexaria Bioscience Corp. generate each year?
Lexaria Bioscience Corp. (:LEXX) has a recorded annual revenue of $226,208.
-
How much profit does Lexaria Bioscience Corp. generate each year?
Lexaria Bioscience Corp. (:LEXX) has a recorded net income of $226,208. Lexaria Bioscience Corp. has generated $-1.01 earnings per share over the last four quarters.
-
What is Lexaria Bioscience Corp.'s price-to-earnings ratio?
Lexaria Bioscience Corp. (:LEXX) has a price-to-earnings ratio of -6.14 and price/earnings-to-growth ratio is -0.19.
